Stromal COX-2 signaling are correlated with colorectal cancer: A review

被引:23
|
作者
Su, Chen-Wei [1 ]
Zhang, Yuan [2 ]
Zhu, Ying-Ting [1 ]
机构
[1] TissueTech Inc, Ocular Surface Ctr, Ocular Surface Res & Educ Fdn, R&D Dept, Miami, FL USA
[2] Dalian Cent Hosp, Dalian, Liaoning Provin, Peoples R China
关键词
Cyclooxygenase-2; Prostaglandin; Proliferation; Invasion; Colorectal; Cancer; NF-KAPPA-B; COLON-CARCINOMA CELLS; PROSTAGLANDIN E-2; CONSTITUTIVE EXPRESSION; PEROXISOME PROLIFERATOR; MEDIATES PROLIFERATION; SUBTYPE EP1; CYCLOOXYGENASE-2; GROWTH; ACTIVATION;
D O I
10.1016/j.critrevonc.2016.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclooxygenase-2 (COX-2) and its product prostaglandin E-2 (PGE(2)) play a critical role in development and progression of colorectal cancer. Yet the detailed mechanistic pathways of COX-2 mediated signaling are still controversial and the role of COX-2 interaction in epithelial-stromal compartments on colorectal carcinogenesis is not well-understood either. In this review, we provide experimental evidence to support that (1) COX-2 signaling plays a major role in development and progression of colorectal cancer; (2) Stromal fibroblasts are a major source of COX-2 and PGE2; (3) Stromal-epithelial interaction mediated by COX-2 signaling promotes colorectal carcinogenesis and (4) Inhibition of stromal COX-2 signaling is necessary to control colorectal cancer. In conclusion, the evidences summarized in the review reflect recent advances and insight in mechanistic studies of colorectal cancer which can help the audiences to further understand the etiology and the control of this disease. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [41] Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer
    Patrignani, P
    TOXICOLOGY LETTERS, 2000, 112 : 493 - 498
  • [42] Association of COX-2 expression with lymphocyte infiltration in colorectal cancer.
    Wu, Zehua
    Zhang, Jianwei
    Cai, Yue
    Yang, Liu
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
    Richard M. Peek
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S50 - S56
  • [44] Reduced COX-2 protein in colorectal cancer with defective mismatch repair
    Karnes, WE
    Shattuck-Brandt, R
    Burgart, LJ
    DuBois, RN
    Tester, DJ
    Cunningham, JM
    Kim, CY
    McDonnell, SK
    Schaid, DJ
    Thibodeau, SN
    CANCER RESEARCH, 1998, 58 (23) : 5473 - 5477
  • [45] IS THERE A PLACE FOR PRACTICAL CHEMOPREVENTION OF COLORECTAL CANCER IN LIGHT OF COX-2 HETEROGENEITY?
    Lewitowicz, Piotr
    Koziel, Dorota
    Gluszek, Stanislaw Zbigniew
    Matykiewicz, Jaroslaw
    Wincewicz, Andrzej
    Horecka-Lewitowicz, Agata
    Nasierowska-Guttmejer, Anna
    POLISH JOURNAL OF PATHOLOGY, 2014, 65 (04) : 276 - 282
  • [46] IL1β-mediated Stromal COX-2 signaling mediates proliferation and invasiveness of colonic epithelial cancer cells
    Zhu, Yingting
    Zhu, Min
    Lance, Peter
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (19) : 2520 - 2530
  • [47] Colorectal cancer chemoprevention: Aspirin, other NSAID and COX-2 inhibitors
    Kune, GA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 2000, 70 (06): : 452 - 455
  • [48] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
    Peek, RM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (Suppl 1) : S50 - S56
  • [49] COX-2 inhibitors: A review
    Houston, AM
    Teach, SJ
    PEDIATRIC EMERGENCY CARE, 2004, 20 (06) : 396 - 399
  • [50] The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis
    Purnama, Andriana
    Lukman, Kiki
    Rudiman, Reno
    Prasetyo, Dwi
    Fuadah, Yoni
    Nugraha, Prapanca
    Candrawinata, Valeska Siulinda
    HELIYON, 2023, 9 (10)